Head-to-head dispatch
Curex vs Found
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Identical $199 pricing on both molecules, plus oral routes and nationwide reach — simple math for switchers.
Marked down on: No brand-name access
FDAWarning letter issued to Curex in September 2025. See the FDA warning-letter database.
Desk Score
The widest medication bench in the ranking — compounded, six brand-name products and oral orforglipron — priced off a membership rather than a sticker.
Marked down on: The $99/mo headline is a longer-plan floor — Found's own FAQ says the 3, 6 and 12-month plans are what keep the monthly cost down, so month-to-month costs meaningfully more
Curex takes this head-to-head with the higher Desk Score, 88/100 (B+) against 81/100 (B−) for Found. Found still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Curex
88/100
B+
Found
81/100
B−
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Curex | Found |
|---|---|---|
| Semaglutide | $199/mo | $289/mo cash month-to-month · $169/mo on a 12-month prepay paid up front ($2,028); the advertised $99 is the in-network INSURANCE rate and still precedes a ~$30 per-visit copay |
| Tirzepatide | $199/mo | $289/mo cash month-to-month · $169/mo on a 12-month prepay paid up front ($2,028); one program price covers both molecules |
| Coverage | All 50 states | All 50 states |
| Brand-name | Compounded only | Yes |
| Oral option | Yes | Yes |
| Best for | People who may switch between semaglutide and tirzepatide and want one predictable price for either. | People who want insurance run against their clinical visits and a clinician free to move them between compounded, brand-name and oral routes. |
| Desk Score | 88/100B+ | 81/100B− |
The verdict
Desk pick — CurexCurex takes this head-to-head with the higher Desk Score, 88/100 (B+) against 81/100 (B−) for Found. Found still holds its ground where its strengths line up with yours.
Choose Curex if…
People who may switch between semaglutide and tirzepatide and want one predictable price for either.
$199/mo sema · $199/mo tirz · All 50 states
FDAWarning letter issued to Curex in September 2025. See the FDA warning-letter database.
Choose Found if…
People who want insurance run against their clinical visits and a clinician free to move them between compounded, brand-name and oral routes.
$289/mo cash month-to-month · $169/mo on a 12-month prepay paid up front ($2,028); the advertised $99 is the in-network INSURANCE rate and still precedes a ~$30 per-visit copay sema · $289/mo cash month-to-month · $169/mo on a 12-month prepay paid up front ($2,028); one program price covers both molecules tirz · All 50 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Curex · Found.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- Curex vs CoreAge Rx
- Found vs Vaylen
- Curex vs Strut Health
- Found vs Ondra Health
- Curex vs Invigor Medical
- Found vs Vytora Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.